New peptide-based therapies for metabolic diseases.
Culler
M D
MD
Biomeasure Incorporated, IPSEN, 27 Maple Street, Milford, MA 01757, USA. michael.culler@ipsen.com
D000818:Animals; D054439:Ghrelin / Q000031:analogs & derivatives / Q000494:pharmacology; D019382:Human Growth Hormone / Q000819:agonists / Q000378:metabolism; D006801:Humans; D008659:Metabolic Diseases / Q000188:drug therapy*; D009765:Obesity / Q000188:drug therapy; D036361:Peptide Hormones / Q000494:pharmacology / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use*
C492347:BIM28163; D054439:Ghrelin; D036361:Peptide Hormones; D010455:Peptides; D019382:Human Growth Hormone